Published in Cancer Weekly, August 1st, 2006
Study 1: Recent research from South Korea has chronicled the effects of hepatic arterial infusion (HAI) alternating with systemic chemotherapy in patients with non-resectable hepatic metastases from colorectal cancer.
"HAI chemotherapy has a number of limitations, including a low rate of complete response and frequent extrahepatic recurrence, in colorectal cancer patients with non-resectable hepatic metastases," wrote J.C. Kim and colleagues, University of Ulsan.
They explained, "Twenty-nine colorectal cancer patients with non-resectable...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.